961.12 History History: 1971 c. 219; 1995 a. 448 s. 154; Stats. 1995 s. 961.12.
961.13 961.13 Schedule I tests.
961.13(1m)(1m) The controlled substances board shall add a substance to schedule I upon finding that the substance:
961.13(1m)(a) (a) Has high potential for abuse;
961.13(1m)(b) (b) Has no currently accepted medical use in treatment in the United States; and
961.13(1m)(c) (c) Lacks accepted safety for use in treatment under medical supervision.
961.13(2m) (2m) The controlled substances board may add a substance to schedule I without making the findings required under sub. (1m) if the substance is controlled under schedule I of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.13 History History: 1971 c. 219; 1995 a. 448 ss. 155, 156, 471; Stats. 1995 s. 961.13.
961.14 961.14 Schedule I. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I:
961.14(2) (2)Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.14(2)(a) (a) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- phenylethyl)-4-piperidinyl]-N-phenylacetamide);
961.14(2)(ag) (ag) Acetylmethadol;
961.14(2)(am) (am) Allylprodine;
961.14(2)(b) (b) Alphacetylmethadol (except levo-alphacetylmethadol (LAAM));
961.14(2)(bm) (bm) Alphameprodine;
961.14(2)(c) (c) Alphamethadol;
961.14(2)(cd) (cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(cg) (cg) Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(cm) (cm) Benzethidine;
961.14(2)(d) (d) Betacetylmethadol;
961.14(2)(dg) (dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(dm) (dm) Betameprodine;
961.14(2)(e) (e) Betamethadol;
961.14(2)(em) (em) Betaprodine;
961.14(2)(er) (er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(f) (f) Clonitazene;
961.14(2)(fm) (fm) Dextromoramide;
961.14(2)(gm) (gm) Diampromide;
961.14(2)(h) (h) Diethylthiambutene;
961.14(2)(hg) (hg) Difenoxin;
961.14(2)(hm) (hm) Dimenoxadol;
961.14(2)(j) (j) Dimepheptanol;
961.14(2)(jm) (jm) Dimethylthiambutene;
961.14(2)(k) (k) Dioxaphetyl butyrate;
961.14(2)(km) (km) Dipipanone;
961.14(2)(m) (m) Ethylmethylthiambutene;
961.14(2)(mm) (mm) Etonitazene;
961.14(2)(n) (n) Etoxeridine;
961.14(2)(nm) (nm) Furethidine;
961.14(2)(p) (p) Hydroxypethidine;
961.14(2)(pm) (pm) Ketobemidone;
961.14(2)(q) (q) Levomoramide;
961.14(2)(qm) (qm) Levophenacylmorphan;
961.14(2)(qs) (qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- piperidinyl]-N-phenylpropanamide);
961.14(2)(r) (r) Morpheridine;
961.14(2)(rg) (rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
961.14(2)(rj) (rj) 3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(rm) (rm) Noracymethadol;
961.14(2)(s) (s) Norlevorphanol;
961.14(2)(sm) (sm) Normethadone;
961.14(2)(t) (t) Norpipanone;
961.14(2)(tg) (tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
961.14(2)(tm) (tm) Phenadoxone;
961.14(2)(u) (u) Phenampromide;
961.14(2)(um) (um) Phenomorphan;
961.14(2)(v) (v) Phenoperidine;
961.14(2)(vg) (vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
961.14(2)(vm) (vm) Piritramide;
961.14(2)(w) (w) Proheptazine;
961.14(2)(wm) (wm) Properidine;
961.14(2)(wn) (wn) Propiram;
961.14(2)(x) (x) Racemoramide;
961.14(2)(xm) (xm) Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(xr) (xr) Tilidine;
961.14(2)(y) (y) Trimeperidine.
961.14(3) (3)Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(3)(a) (a) Acetorphine;
961.14(3)(b) (b) Acetyldihydrocodeine;
961.14(3)(c) (c) Benzylmorphine;
961.14(3)(d) (d) Codeine methylbromide;
961.14(3)(e) (e) Codeine-N-oxide;
961.14(3)(f) (f) Cyprenorphine;
961.14(3)(g) (g) Desomorphine;
961.14(3)(h) (h) Dihydromorphine;
961.14(3)(hm) (hm) Drotebanol;
961.14(3)(j) (j) Etorphine, except its hydrochloride salts;
961.14(3)(k) (k) Heroin;
961.14(3)(m) (m) Hydromorphinol;
961.14(3)(n) (n) Methyldesorphine;
961.14(3)(p) (p) Methyldihydromorphine;
961.14(3)(q) (q) Morphine methylbromide;
961.14(3)(r) (r) Morphine methylsulfonate;
961.14(3)(s) (s) Morphine-N-oxide;
961.14(3)(t) (t) Myrophine;
961.14(3)(u) (u) Nicocodeine;
961.14(3)(v) (v) Nicomorphine;
961.14(3)(w) (w) Normorphine;
961.14(3)(x) (x) Pholcodine;
961.14(3)(y) (y) Thebacon.
Loading...
Loading...
This is an archival version of the Wis. Stats. database for 2013. See Are the Statutes on this Website Official?